Immune remodeling and myeloid signature in the bone marrow niche of MYCN-driven neuroblastoma
Bethel Tesfai Embaie, Adele M. Alchahin, Lilly Velentza, Thale Kristin Olsen, Ioana Maria Gavriliuc, Shenglin Mei, Ninib Baryawno · 2026
Read Immune remodeling and myeloid signature in the bone marrow niche of MYCN-driven neuroblastoma by Bethel Tesfai Embaie, Adele M. Alchahin, Lilly Velentza, Thale Kristin Olsen, Ioana Maria Gavriliuc, Shenglin Mei, Ninib Baryawno (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578270.txt.
Description
Bethel Tesfai Embaie and co-authors map how a childhood nerve tumor reshapes the bone marrow, in a 2026 study. The tumor, neuroblastoma with extra copies of the MYCN gene, often spreads to marrow and carries a poor outlook. Using single-cell RNA reads, the team compared marrow from normal mice and from mice bred to grow this tumor. They then checked the match with human cases.
Tumor mice held more neutrophils and a distinct myeloid cell group, and fewer growing B cells. Signal paths between cells also shifted toward new routes. The distinct cell group bore genes tied to worse survival in patients. The authors point to fatty-acid binding cells and one signal family as targets for future therapy.
Catalog record
| CREATOR | Bethel Tesfai Embaie, Adele M. Alchahin, Lilly Velentza, Thale Kristin Olsen, Ioana Maria Gavriliuc, Shenglin Mei, Ninib Baryawno |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |